What a coincidence...me too. Maybe bio night owls think alike. For a company down as much as OSIP is from the beginning of the year, this month and December are the absolute worst months to go in a slump, because the tax-loss selling exacerbates the plunge. Big risk for most biotechs right now, but also could be setting up for a snapback rally.